PRIMA BCI

Biohybrid retinal implant brain-computer interface designed to restore vision. In clinical trials. It is a biometric system designed for physical AI applications. Key specifications include Form Factor: biometric, Maturity: pilot.

Yes. PRIMA BCI is independently verified in real-world operation on the DEPLOY registry, confirmed at named deployment sites with primary sources: not a concept, render, or demo-only.

PRIMA BCI is made by Science Corp, based in Alameda, California, USA, founded in 2021.

2 verified deployments of PRIMA BCI are on the DEPLOY registry, including at Germany, Europe, United States (multiple hotel chains).

PRIMA BCI is in pilot deployments with named customers and is not yet broadly for sale.

On the DEPLOY registry, comparable biometric robots to PRIMA BCI include Blackrock Neuroport Array, BrainQ Non-Invasive BCI, Neko Body Scan, RNS System.

PRIMA BCI and Blackrock Neuroport Array (Blackrock Neurotech · 5 deployments) are both biometric robots on the DEPLOY registry. PRIMA BCI has 2 verified deployments on record. Compare both records for specs, safety, deployments, and verified-vs-claimed autonomy.

On DEPLOY's intelligence score, which blends verified deployments, safety, adoption, media, and IP signals, PRIMA BCI ranks in roughly the top 36% of biometric models tracked by the registry.

PRIMA BCI is at the pilot stage on the DEPLOY maturity ladder (research, prototype, pilot, commercial, production). Pilot stage means at least one named-customer trial deployment is verified.

PRIMA BCI has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.